Evaluation of the Prognostic Value of Preoperative Quadriceps and Respiratory Muscle Thickness by Ultrasound Measurement in Cardiac and Thoracic Surgery Patients (MUSCA)

January 28, 2026 updated by: Centre Hospitalier Universitaire Dijon

Evaluation of the Prognostic Value of Preoperative Quadriceps and Respiratory Muscle Thickness by Ultrasound Measurement in Cardiac and Thoracic Surgery Patients: a Prospective Observational Study

Cardiac and thoracic surgery are major procedures. In order to estimate the operative risk, many scores have been developed, including the Euroscore 2 in cardiac surgery. However, the Euroscore has limitations since it does not assess all the parameters that may influence postoperative complications, such as the patient's general condition or the status of his or her functional reserves.

However, it has been shown that the preoperative functional reserves have a significant impact on the patient's risk of developing postoperative complications following major surgery. In addition, there is a strong association between cardiac failure and a well-described decrease in peripheral muscle lean mass (sarcopenia) in patients older than 65 years.

Usually, a nutritional assessment is performed during the pre-anesthesia consultation. This assessment is based on clinical and biological criteria that are not totally predictive of the patient's functional reserve status.

Lean body mass (muscle) is a well-validated marker for the assessment of patients' functional reserves. However, the techniques used to date are complex and require radiation.

This study aims to use ultrasound of muscle groups (respiratory muscles - Quadriceps muscle - Diaphragm) to study the relationship between preoperative muscle mass and postoperative complications in patients over 65 years of age undergoing cardiac or thoracic surgery.

This is a prospective observational study to be conducted at the Dijon University Hospital by the cardiovascular anesthesia-intensive care department. A total of 300 patients will participate in this study, and we have planned to complete the project over a 2-year period. The participating patients (if they do not present any exclusion criteria and are not opposed to inclusion) will be included and undergo a muscle ultrasound in the cardiovascular surgery department or the thoracic and pulmonary surgery department the day before their intervention.

Study Overview

Study Type

Observational

Enrollment (Actual)

301

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dijon, France, 21000
        • Chu Dijon Bourgogne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patient requiring cardiac or thoracic surgery

Description

Inclusion Criteria:

  • Patient 65 years or older
  • Patients who have not objected to their inclusion in the study
  • Any patient requiring elective cardiac surgery, with extracorporeal circulation extracorporeal circulation OR
  • Any patient requiring lung surgery with resection of at least one lobe

Exclusion Criteria:

  • pneumectomy
  • Person who is not affiliated to national health insurance
  • Person subject to a measure of legal protection (curatorship, guardianship)
  • Pregnant, parturient or breastfeeding women
  • Major unable to express consent
  • Persons with amputations of the proximal segment of a lower limb
  • Persons suffering from a pre-existing neuromuscular pathology, tetra or paraplegia
  • Person who must undergo emergency surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cardiology patient
Patient requiring cardiac surgery with bypass
the measurements will be performed during inspiration and expiration to take into account variability during the respiratory cycle. The examination is performed bilaterally and comparatively and lasts between 3 and 5 minutes.
The examination is performed bilaterally and comparatively and takes between 3 and 5 minutes.
The examination is performed bilaterally and comparatively and takes between 5 and 10 minutes.
measurements performed bilaterally on a patient in a half-sitting position at 45° and in spontaneous ventilation
In spontaneous ventilation, lying down, arms by the side of the body, palms up, head down
Pneumology patient
Patient requiring lung surgery with resection of at least one lobe
the measurements will be performed during inspiration and expiration to take into account variability during the respiratory cycle. The examination is performed bilaterally and comparatively and lasts between 3 and 5 minutes.
The examination is performed bilaterally and comparatively and takes between 3 and 5 minutes.
The examination is performed bilaterally and comparatively and takes between 5 and 10 minutes.
measurements performed bilaterally on a patient in a half-sitting position at 45° and in spontaneous ventilation
In spontaneous ventilation, lying down, arms by the side of the body, palms up, head down

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Onset of acute renal failure
Time Frame: Within 30 days after surgery
Within 30 days after surgery
Occurrence of a respiratory complication
Time Frame: Within 30 days after surgery
Occurrence of acute respiratory failure in cardiac surgery and occurrence of a severe extra-respiratory complication according to the european perioperative clinical outcome definition in pulmonary surgery
Within 30 days after surgery
Occurrence of a cardiovascular complication
Time Frame: Within 30 days after surgery
Within 30 days after surgery
Occurrence of an infectious complication
Time Frame: Within 30 days after surgery
Within 30 days after surgery
Death
Time Frame: Within 30 days after surgery
Within 30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 31, 2022

Primary Completion (Actual)

September 26, 2023

Study Completion (Actual)

September 26, 2023

Study Registration Dates

First Submitted

June 7, 2022

First Submitted That Met QC Criteria

June 7, 2022

First Posted (Actual)

June 9, 2022

Study Record Updates

Last Update Posted (Actual)

January 29, 2026

Last Update Submitted That Met QC Criteria

January 28, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thoracic Surgery

Clinical Trials on Ultrasound of the abdominal wall muscles

Subscribe